Candriam Luxembourg S.C.A. Has $4.48 Million Holdings in Metlife Inc (MET)

Candriam Luxembourg S.C.A. trimmed its position in shares of Metlife Inc (NYSE:MET) by 13.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 88,673 shares of the financial services provider’s stock after selling 13,892 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Metlife were worth $4,483,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in MET. Griffin Asset Management Inc. acquired a new stake in shares of Metlife during the 2nd quarter worth $2,424,000. Intl Fcstone Inc. acquired a new stake in shares of Metlife during the 2nd quarter worth $383,000. PGGM Investments increased its holdings in shares of Metlife by 2.3% during the 3rd quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock worth $29,972,000 after buying an additional 12,978 shares during the last quarter. Lincoln Capital Corp increased its holdings in shares of Metlife by 9.6% during the 3rd quarter. Lincoln Capital Corp now owns 75,946 shares of the financial services provider’s stock worth $3,945,000 after buying an additional 6,664 shares during the last quarter. Finally, Hermes Investment Management Ltd. increased its holdings in shares of Metlife by 30.0% during the 3rd quarter. Hermes Investment Management Ltd. now owns 283,208 shares of the financial services provider’s stock worth $14,713,000 after buying an additional 65,438 shares during the last quarter. Institutional investors and hedge funds own 76.55% of the company’s stock.

Metlife Inc (NYSE:MET) opened at $46.64 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.16. The firm has a market cap of $49,080.00, a PE ratio of 11.49, a price-to-earnings-growth ratio of 1.04 and a beta of 1.31. Metlife Inc has a 12-month low of $43.38 and a 12-month high of $55.91.

Metlife (NYSE:MET) last posted its quarterly earnings data on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.41). The firm had revenue of $15.79 billion during the quarter, compared to analysts’ expectations of $15.89 billion. Metlife had a net margin of 5.69% and a return on equity of 8.62%. During the same period in the previous year, the company earned $1.28 earnings per share. equities research analysts predict that Metlife Inc will post 4.97 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a yield of 3.43%. Metlife’s payout ratio is currently 39.41%.

MET has been the subject of a number of research analyst reports. Wells Fargo & Co dropped their price objective on Metlife from $61.00 to $60.00 and set a “buy” rating for the company in a report on Tuesday, January 30th. Deutsche Bank initiated coverage on Metlife in a report on Tuesday, January 2nd. They set a “hold” rating and a $55.00 price objective for the company. Zacks Investment Research upgraded Metlife from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a report on Thursday, November 9th. ValuEngine cut shares of Metlife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 9th. Finally, Sandler O’Neill cut shares of Metlife from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and nine have given a buy rating to the company’s stock. Metlife presently has a consensus rating of “Hold” and a consensus target price of $57.77.

COPYRIGHT VIOLATION WARNING: This news story was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/17/candriam-luxembourg-s-c-a-has-4-48-million-holdings-in-metlife-inc-met.html.

About Metlife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply